News

The 2014 Pregnancy Summit

Off
Monday, 06 October 2014 09:00 –
Wednesday, 08 October 2014 17:00
Cineworld: The O2
Peninsula Square
London
SE10 0DX
United Kingdom

This year our pregnancy summit will discuss our current understanding of pre-eclampsia research and treatments.  The last day will focus on the technologies currently available to assess pregnancy and pregnancy-associated conditions. This event has CPD accreditation.

Who Should Attend
Anyone working in the field of pregnancy and diagnosing pregnancy-related illnesses and pregnancy outcome will find this event beneficial.  This includes Scientists,Obstetricians, Gynaecologists, Midwives, Clinical Chemists and Pharmaceutical and Medical devices professionals.

The deadline for abstract submissions for oral presentation is July 10th 2014. Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at 

 

Program Outline

Day 1: Pre-eclampsia research

A maternal inflammatory response is characteristic for the maternal preeclampsia syndrome. During such a response inflammatory and angiogenic factors play crucial roles in the onset of and also sustaining the syndrome. The relation between these factors is subject for many studies world wide to improve the prognosis of preeclampsia and with a better prognosis the morbility and mortality of the syndrome should be improved. 

Session Chair:  Mr Joost Schuitemaker, Managing Director, IQ Products, The Netherlands

Day 2: Pre-eclampsia treatment and management

Session Chair: To be confirmed

Day 3: Technologies to assess pregnancy and pregnancy-associated conditions

Session Chair:  Professor Ray Iles, Chief Scientist, The ELK-Foundation for Health Research and MAP Diagnostics, UK

Talks Include:

Talk title to be confirmed
Mr Joost Schuitemaker, Managing Director, IQ Products, The Netherlands

How can biomarkers be used to improve the management of pre-eclampsia

Professor Andrew Shennan, Kings College London, UK
Preeclampsia Human Placental Model
Professor Nandakumaran Moorkath, Faculty of Medicine, University of Kuwait
Central aortic blood pressure, aortic stiffness and peripheral blood pressure in healthy pregnant women and women with arterial hypertension in pregnancy. Is there a difference in profile and chance to predict complications based on those features
Dr Ludwina Szczepaniak-Chichel, Department of Hypertensiology, Angiology and Internal Medicine, Poznań University of Medical Sciences, Poland
The immune system in the  pathophysiology of preeclampsia
Dr Estibalitz Laresgoiti, MD, MSc, PhD, Universidad Panamericana, Mexico
Podocyturia as a diagnostic and prognostic marker of preeclampsia
Dr Vesna D. Garovic, Professor of Internal Medicine, Division of Nephology+Hypertension + Dept of Obstetrics+Gynaecology, Mayo Clinic, USA
Role of metabolic Syndrome factors in pre-eclampsia
Dr Shipra Sonkusare, Dept. of Obstetrics + Gynaecology,  Manipal University, India
Anesthetic Goals of Labor Analgesia in Preeclampsia
Dr Ayten Saracoglu, Assistant Professor, Department of Anesthesiology and Reanimation, Istanbul Bilim University School, Turkey
Vitamin D3 deficiency/treatment during pregnancy and complications including preeclampsia
Dr Stella Nowicki, Professor Microbiology and Immunology, Meharry Medical College, Nashville, TN, USA
The hemostatic changes in preeclampsia, is there a place for anticoagulation treatment for the prevention of this syndrome
Professor Offer Erez, Director of Risk Management and Patients Safty Unit, Acting Director Maternal Fetal Medicine Unit, Soroka University Medical Center, Ben Gurion University of the Negev, Israel
Regional versus General Anesthesia for C/S in Severe Preeclampsia
Dr Kemal Tolga Saracoglu, Department of Anesthesiology and Reanimation, Marmara
University School of Medicine, Istanbul Turkey
Angiogenic Factors in Preeclampsia: Potential for Diagnosis and Treatment
Dr Sarosh Rana, MD, Assistant Professor, Harvard Medical School/ Beth Israel Deaconess Medical Center, Boston, MA, USA

The talk will summarizes new observations of key roles for circulating angiogenic factors in diagnosing, managing and, treating preeclampsia. We will review the literature that alterations in circulating angiogenic factors in preeclampsia correlate with the diagnosis and adverse outcomes particularly when the disease presents prematurely. Measurement of these angiogenic biomarkers has also shown to differentiate preeclampsia and its complications from other disorders that present with similar clinical profiles. We will also review the evidence that modulating these factors can have therapeutic effects suggesting a future role for angiogenic factors in treatment and prevention of preeclampsia.


The role of nutrition and genetics during pregnancy

Dr Anne Parle-McDermott, Lecturer in Genetics, Dublin City University, Ireland
The B vitamin, folate, is an important nutrient during pregnancy in the prevention of birth defects.  While it is widely accepted that a folic acid supplement can prevent neural tube defects (NTD) if taken periconceptionally,  the exact mechanism of how prevention is occurring is not clear.  What also needs to be considered, is whether folate supplementation has any additional effects outside of NTD prevention.   This talk will describe the latest discoveries in relation to how human genetic variation can impact on pregnancy and how folic acid supplement could potentially be modifying  our genome.

Catheter Ablation of Arrhythmia in Pregnant Women
Dr John Ferguson, Associate Professor, University of Virginia Medical Center, USA

Fetal haemodyanic assessment by magnetic resonance imaging
Dr Mike Seed, Pediatric Cardiologist and Radiologist, SickKids, Toronto, Canada
Ultrasound provides high spatial and temporal resolution imaging of the fetal heart and Doppler yields a wealth of information about fetal cardiovascular physiology.  However, due to inherent limitations of the technique, ultrasound is not routinely used to measure an important parameter of haemodynamics; blood flow.  Furthermore, ultrasound provides no information about a second key parameter of cardiovascular function, the oxygen content of blood.  We sought to develop a MRI technique to measure fundamental elements of fetal circulatory physiology including oxygen delivery, oxygen consumption, cardiac output and the distribution of blood flow and oxygen across the fetal circulation.

Information about  prenatal examinations – A challenge in antenatal care
Associate Professor Susanne Georgsson Öhman, Senior Lecturer, Karolinska Institutet Department of women’s and children’s health, Stockholm, Sweden
In Sweden pregnant women are offered ultrasound in the second trimester. Combined Ultrasound and Biochemical screening (CUB) may be offered for risk estimation for chromosomal aberrations but new non invasive test methods with this puspose are in an explosive development. Invasive test; amniocentesis or chorion villus sampling, is offered when the risk for chromosomal aberrations is high due to screening test results, due to the maternal age or due to increased worry. It is essential for the parents to be to have access to correct, non-directive information to be able to make decisions, informed choices, about prenatal examinations, and this is a great challenge for the antenatal health care.

Was the Mona Lisa’s Smile the Result of a Pregnancy-associated Condition
Dr William Maloney, DDS, Clinical Associate Professor, New York University, USA

Latest Euroscicon Tweets

Error: You are not connected to Twitter.